This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Chromatographic Screening to Find Metabolic Diseases, Especially Those Involving the Nervous System

JOHN H. MENKES, M.D.; FREDERICK RICHARDSON, M.D.; SARAH VERPLANCK, B.A.

Arch Neurol. 1962;6(6):462-470.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Within recent years the search for metabolic defects responsible for mental retardation has been greatly intensified. Not only have several new inborn errors of metabolism associated with cerebral malfunction been described,^1-7 but it has also been possible to detect atypical clinical pictures of previously well-characterized diseases, such as phenylketonuria.⁸

One factor responsible for this impetus is the increasingly widespread use of paper chromatography as part of the diagnostic armamentarium of the pediatric neurologist. This procedure demands little in terms of time, space, and cost of operation, and offers a method of analysis for a wide diversity of chemical substances. As a consequence, many clinicians have turned to paper chromatography as a means of detecting abnormal metabolites or abnormal quantities of normal intermediary metabolic products.

For the past 3 years, one of us (J.H.M.) has been screening children suffering from a variety of neurological diseases for possible metabolic defects. . . . [Full Text PDF of this Article]

Author Affiliations
BALTIMORE

Department of Pediatrics, Harriet Lane Home, and Diagnostic and Evaluation Center for Handicapped Children, The Johns Hopkins University and School of Medicine.

Footnotes
Received for publication Dec. 14, 1961.

Joseph P. Kennedy, Jr., Scholar in Mental Retardation (Dr. Menkes).

Presented in part to the Johns Hopkins Medical and Surgical Society, April, 1961.

This research was supported in part by Research Grant B-1620 (awarded to the division of Neuropathology, College of Physicians and Surgeons, Columbia University, by the National Institute of Neurological Diseases and Blindness), Grant M.32.6033 of the U.S. Public Health Service, and the Joseph P. Kennedy, Jr., Foundation for Neuromuscular Disease, Inc.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?